Linagliptin and Vitamin D3 Synergistically Rescue Testicular Steroidogenesis and Spermatogenesis in Cisplatin-Exposed Rats: The Crosstalk of Endoplasmic Reticulum Stress with NF-κB/iNOS Activation

• Published in: Molecules (Basel, Switzerland) Vol. 27; no. 21; p. 7299
• Main Authors: Elrashidy, Rania A, Zakaria, Esraa M, Elmaghraby, Asmaa M, Abd El Aziz, Rasha E M, Abdelgalil, Ranya M, Megahed, Rehab M, Elshiech, Asmaa A, Salama, Doaa E A, Ibrahim, Samah E
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 27.10.2022; MDPI
• Subjects: Analysis; Animals; Chemotherapy; Cholecalciferol - pharmacology; Cholesterol; Cisplatin; Cisplatin - pharmacology; Cytochrome; Dehydrogenases; Dosage and administration; Drug dosages; Endoplasmic reticulum; Endoplasmic Reticulum Stress; Enzymes; Exposure; Fertility; Gene expression; Germ cells; Health aspects; Infertility; Kinases; Leydig cells; Linagliptin; Male; Markers; Metabolism; NF-kappa B - metabolism; NF-κB protein; Nitric-oxide synthase; Oxidative Stress; Proteins; Rats; Reproductive health; Sperm; Spermatogenesis; Steroid hormones; Steroidogenesis; Stress; Testes; Testis; Testosterone; Transcription factors; Tumor necrosis factor-TNF; Vitamin D3; Weight loss; Egypt; United States > US; steroidogenesis; linagliptin; cisplatin; endoplasmic reticulum stress; vitamin D3
• ISSN: 1420-3049; 1420-3049
• DOI: 10.3390/molecules27217299

This study investigated the therapeutic effect of linagliptin and/or vitamin D3 on testicular steroidogenesis and spermatogenesis in cisplatin-exposed rats including their impact on endoplasmic reticulum (ER) stress and NF-κB/iNOS crosstalk. Cisplatin (7 mg/kg, IP) was injected into adult male albino rats which then were orally treated with drug vehicle, linagliptin (3 mg/kg/day), vitamin D3 (10 μg/kg/day) or both drugs for four weeks. Age-matched rats were used as the control group. Serum samples and testes were collected for further analyses. Cisplatin induced testicular weight loss, deteriorated testicular architecture, loss of germ cells and declined serum and intra-testicular testosterone levels, compared to the control group. There was down-regulation of steroidogenic markers including StAR, CYP11A1, HSD3b and HSD17b in cisplatin-exposed rats, compared with controls. Cisplatin-exposed rats showed up-regulation of ER stress markers in testicular tissue along with increased expression of NF-κB and iNOS in spermatogenic and Leydig cells. These perturbations were almost reversed by vitamin D3 or linagliptin. The combined therapy exerted a more remarkable effect on testicular dysfunction than either monotherapy. These findings suggest a novel therapeutic application for linagliptin combined with vitamin D3 to restore testicular architecture, aberrant steroidogenesis and spermatogenesis after cisplatin exposure. These effects may be attributed to suppression of ER stress and NF-kB/iNOS.